Need Help?
Contact Us
Clinical Spotlight - From the desk of Craig Thompson MD and Keith Dawkins MD, Chief Medical Officers, Boston Scientific Clinical Spotlight - From the desk of Craig Thompson MD and Keith Dawkins MD, Chief Medical Officers, Boston Scientific

We are delighted to provide deeper insight into a few of the cutting-edge scientific areas in Interventional Cardiology within Boston Scientific with the release of the latest edition of the Clinical Spotlight. As your peers, it is our pleasure to share the scientific story behind our robust portfolio providing you with the most current product and data news. This edition concentrates on an array of topics: recent data from the PLATINUMTM Diversity Trial, an overview of the benefits and features of the LOTUS EdgeTM TAVR system, insight into the latest US clinical data on the WATCHMANTM device, recent preclinical and clinical SYNERGYTM data, and an overview of new and upcoming PCI technologies. Enjoy!
 

Best,

Craig A. Thompson, MD
Senior Vice President and Chief Medical Officer
Interventional Cardiology

Keith D. Dawkins, MD
Executive Vice President and Global Chief Medical Officer

 


 

CMO Platinum Diversity Trial Primary Endpoints CMO Platinum Diversity Trial Primary Endpoints

Primary Endpoint of the PLATINUM Diversity Trial Presented at TCT 2016

Dr. Juan Granada discusses the importance of studying under-represented patient populations with co-principal investigator Dr. Wayne Batchelor.

View the video


LOTUS Edge Technology Overview and Latest Clinical Evidence

Review the features and benefits of next generation TAVR system LOTUS Edge along with the most current data.

See more


 

The WATCHMAN™ Experience in Perspective The WATCHMAN™ Experience in Perspective

The WATCHMAN™ Experience in Perspective

Read the perspectives of Dr. Reddy and Dr. Holmes on the recent WATCHMAN™ Post-FDA Approval and initial US clinical experience, and access a summary of Boston Scientific’s training resources.

Read more


 

SYNERGY: Optimal Healing and Safety SYNERGY: Optimal Healing and Safety

SYNERGY: Optimal Healing and Safety

View preclinical and clinical data demonstrating evidence of optimal healing with the SYNERGY stent, learn about the recent FDA approval of SYNERGY for diabetic patients, and view the most recent SYNERGY clinical data presentations.

View data


 

PCI Technology Report PCI Technology Report

PCI Technology Report

Hear experts address new and upcoming PCI Technologies

Watch CMO Craig Thompson, Tim Girton, Boston Scientific’s VP of IC R&D, and Dr. Colm Hanratty, Chief of Clinical Cardiology at Belfast Hospital Trust discuss various new PCI technologies and view Professor de la Torre Hernandez’s study comparing BVS and SYNERGY in terms of clinical resource utilization.

Learn more

Top